Grant ID RP220119
Awarded On February 16, 2022
Title NOVEL METABOLOMICS AND RADIOMICS FOR PREDICTING HCC RISK
Program Academic Research
Award Mechanism Individual Investigator Research Awards for Prevention and Early Detection
Institution/Organization Baylor College of Medicine
Principal Investigator/Program Director Hashem El-Serag
Cancer Sites Gallbladder, Liver and Intrahepatic Bile Duct
Contracted Amount $1,995,127*

*Pending contract negotiation

Lay Summary

Texas has the highest rates of liver cancer, also known as hepatocellular carcinoma (HCC) in the nation. Most cases of HCC arise among patients with chronic liver disease, especially cirrhosis of the liver. Fatty liver disease related to metabolic dysfunction (e.g., diabetes, obesity), also called MAFLD, has become the most common chronic liver disease in the world. Our goal is to reduce death and suffering from HCC. However, except for a small proportion of patients who are diagnosed at an early stage, a cure is not possible. Therefore, prevention of HCC is very important.

Our proposed research study investigates risk factors and novel biomarkers that can be reliably used to identify sub...

Read More